Activation of ANGPTL6, also known as an angiopoietin-related growth factor, has been associated with several beneficial metabolic effects such as protection from steatosis, insulin resistance, and HFD-induced obesity [87]. Here, ANGPTL6 is linked to obesity due to melanocortin 4 receptor deficiency.